Dr. Bijay P. Nair, MD

Dr. Nair practices at Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health.

Dr. Nair's NPI, 1356560684, was assigned on April 25, 2007. Dr. Nair graduated from University of Kerala Medical College in 1999. Dr. Nair holds California license A117287.

Dr. Nair's primary practice is Sutter Medical Center, Sacramento, at 2825 Capitol Avenue, Sacramento, CA 95816 in Sacramento County. The practice phone is (916) 454-2222.

Dr. Nair's primary practice is Sutter Medical Center, Sacramento in Sacramento, California, part of Sutter Health. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Nair to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nair practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Nair's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Nair is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Nair's licenses on file in 2 states: California and Arkansas.

Dmand AI lists chronic anemia, lung cancer, multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Nair treats.

CMS data shows 880 Medicare services from Dr. Nair across 13 procedure codes in 2024, for 300 Medicare patients. Medicare paid $82,828 for them.

CMS counts 300 Medicare patients who saw Dr. Nair in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nair's median patient age at 69, with 49% women.

In 2024, Dr. Nair wrote 640 Medicare Part D claims for 129 patients. 80% of them were for generic drugs. CMS names the drug for 404 of them, across 13 drugs with 11 or more claims each, at $143,579 in total drug cost. In 2023, CMS named 482 claims across 20 drugs.

Dr. Nair accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nair as offering telehealth.

Dmand AI links 36 papers to Dr. Nair, published from 2008 to 2015. 2012 was the busiest year, with 13. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Gene Expression Profiling. Dr. Nair has published most often in Blood. Dr. Nair's most frequent co-authors are Bart Barlogie, MD, Sarah Waheed, MD and Frits Van Rhee, MD.

CMS Open Payments shows 13 general payments to Dr. Nair from 12 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 50% of the total. Abbott Laboratories paid the most, $600.

Dr. Nair graduated from University of Kerala Medical College in 1999. Dr. Nair is a member of ASCO and ASH.

Dr. Nair is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 4. Check the plan with the practice before a visit.